Andrew D. Dickinson - Nov 10, 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Financial Officer
Signature
/s/ Amy Kim by Power of Attorney for Andrew D. Dickinson
Stock symbol
GILD
Transactions as of
Nov 10, 2022
Transactions value $
-$70,293
Form type
4
Date filed
11/14/2022, 11:49 AM
Previous filing
Sep 12, 2022
Next filing
Dec 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +1.91K +2.83% 69.5K Nov 10, 2022 Direct F1
transaction GILD Common Stock Tax liability -$70.3K -851 -1.22% $82.60 68.7K Nov 10, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -1.91K -4.03% 45.5K Nov 10, 2022 Common Stock 1.91K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.